Your browser doesn't support javascript.
loading
A four-group urine risk classifier for predicting outcomes in patients with prostate cancer.
Connell, Shea P; Yazbek-Hanna, Marcelino; McCarthy, Frank; Hurst, Rachel; Webb, Martyn; Curley, Helen; Walker, Helen; Mills, Rob; Ball, Richard Y; Sanda, Martin G; Pellegrini, Kathryn L; Patil, Dattatraya; Perry, Antoinette S; Schalken, Jack; Pandha, Hardev; Whitaker, Hayley; Dennis, Nening; Stuttle, Christine; Mills, Ian G; Guldvik, Ingrid; Parker, Chris; Brewer, Daniel S; Cooper, Colin S; Clark, Jeremy.
  • Connell SP; Norwich Medical School, University of East Anglia, Norwich, UK.
  • Yazbek-Hanna M; Norwich Medical School, University of East Anglia, Norwich, UK.
  • McCarthy F; Institute of Cancer Research, Sutton, UK.
  • Hurst R; Norwich Medical School, University of East Anglia, Norwich, UK.
  • Webb M; Norwich Medical School, University of East Anglia, Norwich, UK.
  • Curley H; Norwich Medical School, University of East Anglia, Norwich, UK.
  • Walker H; Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.
  • Mills R; Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.
  • Ball RY; Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.
  • Sanda MG; Department of Urology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.
  • Pellegrini KL; Department of Urology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.
  • Patil D; Department of Urology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.
  • Perry AS; School of Biology and Environmental Science, Science West, University College Dublin, Dublin 4, Ireland.
  • Schalken J; Nijmegen Medical Centre, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Pandha H; Faculty of Health and Medical Sciences, The University of Surrey, Guildford, UK.
  • Whitaker H; Molecular Diagnostics and Therapeutics Group, University College London, London, UK.
  • Dennis N; Institute of Cancer Research, Sutton, UK.
  • Stuttle C; Institute of Cancer Research, Sutton, UK.
  • Mills IG; School of Medicine, Dentistry and Biomedical Sciences, Institute for Health Sciences, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • Guldvik I; Centre for Molecular Medicine, University of Oslo, Oslo, Norway.
  • Parker C; Centre for Molecular Medicine, University of Oslo, Oslo, Norway.
  • Cooper CS; Royal Marsden Hospital, Sutton, UK.
  • Clark J; Norwich Medical School, University of East Anglia, Norwich, UK.
BJU Int ; 124(4): 609-620, 2019 Oct.
Article en En | MEDLINE | ID: mdl-31106513

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2019 Tipo del documento: Article